当前位置：首页>产品中心>单抗/多抗>InVivoMAb anti-Human CXCL12/SDF-1 beta Antibody|InVivoMAb抗人CXCL12/SDF-1β抗体(靶标：人CXC趋化因子配体12/基质细胞衍生因子1β)

InVivoMAb anti-Human CXCL12/SDF-1 beta Antibody|InVivoMAb抗人CXCL12/SDF-1β抗体(靶标：人CXC趋化因子配体12/基质细胞衍生因子1β)

产品描述	Iv0090 is a human IgG monoclonal antibody targeting CXCL12α, β, and γ. It blocks CXCL12 binding to CXCR4 and CXCR7 and inhibits CXCL12-driven cell migration in vitro. In vivo, Iv0090 significantly inhibits tumor growth and metastasis, reduces arthritis severity in mouse CIA models, and decreases laser-induced choroidal neovascularization by 50%.
形态	Liquid
宿主种属	Human
克隆性	Monoclonal
抗体亚型	IgG1, kappa
纯度	>95% as determined by SDS-PAGE.
纯化方式	Protein A/G purified from cell culture supernatant.
浓度	2.07 mg/ml
内毒素水平	Please contact with the lab for this information.
应用	ELISA, Neutralization
种属反应性	Human
靶标	Intercrine reduced in hepatomas, hSDF-1, Stromal cell-derived factor 1, SDF-1, Pre-B cell growth-stimulating factor, SDF1, SDF1A, C-X-C motif chemokine 12, SDF1B, CXCL12, IRH, PBSF, hIRH
储存缓冲液	0.01M PBS, pH 7.4.
稳定性和储存	Use a manual defrost freezer and avoid repeated freeze-thaw cycles. Store at 4°C short term (1-2 weeks). Store at -20°C 12 months. Store at -80°C long term.
登录号	P48061
备注	For research use only. Not suitable for clinical or therapeutic use.

【仅供科学研究使用】

相关产品: